(4-Vinylphenyl)methanamine (stabilized with MEHQ), 95.0%, 1g

(S)-2-(6-Benzhydrylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole, 97%, 100mg

Quinoxaline-2(1h)-thione, 98%, 1g

tert-Butyl 4-(prop-2-yn-1-yl)piperidine-1-carboxylate, 97%, 1g

Tetrabutylammonium hydroxide, 40% in water, 250 ml, glass packaging

(2S,4S)-1-BOC-4-METHYLPYRROLIDINE-2-CARBOXYLIC ACID ETHYL ESTER, 97.0%, 1g

C-(1-Isopropyl-pyrrolidin-3-yl)-methylamine, 95.0%, 5g

7-Nitroindazole, >98%, 500g

Dimethylisopropylchlorosilane [Dimethylisopropylsilylating Agent]>90.0%(GC)5mL

2-(Diphenylphosphino)benzaldehyde, 95.0%, 100g

tert-Butyl 3-(hydroxymethyl)phenethylcarbamate, 97%, 5g

2,5-DICHLOROPYRIMIDINE-4-CARBOXYLIC ACID, 95%, 1g

(3-TRIFLUOROMETHYL-PYRROLIDIN-3-YL)-METHANOL HCL, 95.0%, 250mg